Fig. 6From: Initial absolute monocyte count as an immune biomarker for clinical response in acute myeloid leukemia with monocytic differentiationThe 3-year disease-free survival analysis in different subgroups. a The 3-year disease-free survival as regard the initial AMC (absolute monocyte count) level. b The 3-year disease-free survival as regard the AML-subgroupsBack to article page